简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2020-01-07 16:04 STEER Gives Boost for Horlicks Production, GSK Acknowledges Technology
2020-01-03 14:46 PMC Group Completes Acquisition of Lanxess’ Organotin Specialties Business Assets
2020-01-03 10:35 IWBI Welcomes New Organizations to Its Growing Membership Program
2019-12-31 09:16 Clover Biopharmaceuticals Initiates Phase III Study of Etanercept Biosimilar Candidate SCB-808 in China
2019-12-24 18:53 Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine
2019-12-24 14:46 BONOTOX Enters Global Market with the World's First Artificial Veil Cream
2019-12-24 09:40 Mary Kay Inc. Caps Off Landmark Scientific Credentialing Year at 73rd Society of Cosmetic Chemists Meeting
2019-12-23 16:26 Clinical Innovations to be acquired by LABORIE Medical Technologies
2019-12-23 12:03 5,736 of the World’s Poorest People Received the Gift of Sight in 2019 at the Tej Kohli Cornea Institute
2019-12-20 17:48 Masimo and Dräger Expand Licensing Agreement to Add Masimo Brain Monitoring and Capnography Technologies
2019-12-18 18:37 Soteria AI Intends to File First Patent, Driving AI Gaming Assistant Into Medical Research
2019-12-18 16:17 Pacific Prime China Wins Two Cigna & CMB Awards
2019-12-18 14:52 FerGene Appoints David Meek President and Chief Executive Officer
2019-12-18 10:25 Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody
2019-12-17 18:58 Covetrus Announces Leadership Changes, Reaffirms 2019 Financial Guidance
2019-12-17 16:38 Sydney Stock Exchange Announces New CEO, First Listing Applications
2019-12-16 09:46 GEDmatch Partners With Genomics Firm Verogen
2019-12-12 16:56 Final results from the NuProtect study demonstrating efficacy of Nuwiq® (simoctocog alfa) in previously untreated patients (PUPs) presented at ASH 2019
2019-12-12 16:29 Seattle Genetics and Takeda Announce Additional Analyses of ADCETRIS® (Brentuximab Vedotin) ECHELON-1 and ECHELON-2 Phase 3 Clinical Trials at the 2019 ASH Annual Meeting
2019-12-12 11:56 PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar, UK Site

Business Wire Weibo

Press Releases

Latest Releases